Lundbeck upgrades annual earnings guidance, cuts revenue outlook
Revenue will end up in the lower end of the spread Lundbeck forecast in early 2021, the Danish pharmaceutical firm informs after closing the first two quarters of this year.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL FRANK CHRISTENSEN
After making it through the first half of 2021, Lundbeck adjusts its annual financial guidance, which was set rather wide in the beginning of the year. Now the group makes both upward and downward adjustments.